Researchers have rapidly identified ways to apply their expertise to help end the pandemic.

There is little evidence that antihypertensive drugs worsen COVID-19, and scientists are instead exploring the idea that such medications—or their downstream effects—may actually alleviate symptoms.

A combination of videography, machine learning, and brain imaging has identified facial expressions and neural activity patterns in mice that are associated with their emotions.

A large-scale shortage of respirators and face shields threatens progress in some labs that are currently trying to ramp up their studies of SARS-CoV-2.

The host transcriptional signature elicited by the coronavirus appears to be less robust and lacks the induction of key antiviral genes.

In recent years, laboratories on the continent have ramped up genomic sequencing capabilities, offering in-country analyses rather than outsourcing the job.

Many researchers have stopped breeding mice, reduced the size of colonies, and established contingency plans in case animal care staff get sick.

Graduate students and postdocs are left wondering about the implications for their academic careers.

Hospitals and commercial companies are testing thousands of patients for COVID-19 daily, but face reagent and supply shortages.